Stay updated on Emricasan in NASH Cirrhosis & Severe Portal Hypertension Clinical Trial
Sign up to get notified when there's something new on the Emricasan in NASH Cirrhosis & Severe Portal Hypertension Clinical Trial page.

Latest updates to the Emricasan in NASH Cirrhosis & Severe Portal Hypertension Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change to the underlying trial record.SummaryDifference0.1%

- Check19 days agoChange DetectedAdded revision v3.5.2 to the history; removed revision v3.5.0.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check47 days agoChange DetectedRevision: v3.5.0 was added and revision: v3.4.3 was deleted in the Record History.SummaryDifference0.1%

- Check54 days agoChange DetectedRecord History now includes Revision: v3.4.3 and removes Revision: v3.4.2.SummaryDifference0.1%

- Check83 days agoChange DetectedThe history now includes Revision: v3.4.2 and the prior funding-status disclaimer was removed.SummaryDifference0.7%

- Check90 days agoChange DetectedA site-wide notice about government funding and operating status was added, and the release version updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

Stay in the know with updates to Emricasan in NASH Cirrhosis & Severe Portal Hypertension Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Emricasan in NASH Cirrhosis & Severe Portal Hypertension Clinical Trial page.